UBS Starts PRA Health Sciences (PRAH) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- L3Harris CEO steps down amid conduct review, shares drop
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
UPDATE: Credit Suisse Starts PRA Health Sciences (PRAH) at Outperform
December 8, 2014 9:23 AM EST(Updated - December 8, 2014 10:30 AM EST)
Credit Suisse initiated coverage on PRA Health Sciences (NASDAQ: PRAH) with an Outperform rating and a price target of $27.00.
"PRAH is a global clinical contract research organization (CRO) that provides outsourced services to support all stages of the clinical... More
Citi Starts PRA Health Sciences (PRAH) at Neutral
December 8, 2014 8:17 AM ESTCiti initiated coverage on PRA Health Sciences (NASDAQ: PRAH) with a Neutral rating and a price target of $24.00.
For an analyst ratings summary and ratings history on PRA Health Sciences click here. For more ratings news on PRA Health Sciences click here.
Shares of PRA Health Sciences closed at $22.06 yesterday.
... MoreBaird Starts PRA Health Sciences (PRAH) at Outperform
December 8, 2014 7:54 AM ESTBaird initiated coverage on PRA Health Sciences (NASDAQ: PRAH) with an Outperform rating and a price target of $28.00.
For an analyst ratings summary and ratings history on PRA Health Sciences click here. For more ratings news on PRA Health Sciences click here.
Shares of PRA Health Sciences closed at $22.06 yesterday.
... MoreWells Fargo Starts PRA Health Sciences (PRAH) at Outperform
December 8, 2014 7:54 AM ESTWells Fargo initiated coverage on PRA Health Sciences (NASDAQ: PRAH) with an Outperform rating and a price target of $25-$26.
For an analyst ratings summary and ratings history on PRA Health Sciences... More
Jefferies Starts PRA Health Sciences (PRAH) at Buy
December 8, 2014 7:42 AM ESTJefferies initiates coverage on PRA Health Sciences (NASDAQ: PRAH) with a Buy rating and a price target of $27.00.
Analyst David Windley comments, "PRA's project-based and functional service solutions combined with the additive RPS client base offer significant cross-selling opportunities and the potential for... More
